|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for loan losses | |||||
| Depreciation expense | |||||
| Amortization of mortgage servicing rights | |||||
| Recovery of valuation allowance on mortgage servicing rights | |||||
| Securities amortization, net | |||||
| Amortization of purchased intangible assets | |||||
| Earnings on cash surrender value of life insurance policies | |||||
| Gain on life insurance benefit | |||||
| Securities gains, net | |||||
| Gain on loans sold | |||||
| Loans originated for sale | |||||
| Proceeds from loan sales | |||||
| Stock based compensation expense | |||||
| Stock portion of director retainer fee expense | |||||
| Gain on sale of foreclosed assets | |||||
| Prepayment penalty on FHLB advance | |||||
| Tax benefit on stock activity | |||||
| Change in other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Net change in short term investments | |||||
| Purchases of securities available for sale | |||||
| Proceeds from calls, maturities, and payments on securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Loan originations and payments, net | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sale of OREO | |||||
| Proceeds from redemption of restricted stock | |||||
| Purchase of restricted stock | |||||
| Proceeds from sale of portfolio loans | |||||
| Proceeds from life insurance benefit | |||||
| Cash received/(paid) from business acquisitions, net | |||||
| Net cash used by investing activities | |||||
| Financing Activities | |||||
| Net change in deposits | |||||
| Net change in other borrowings | |||||
| Proceeds from FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Proceeds from term debt | |||||
| Cash dividends on common stock | |||||
| Purchase of treasury shares | |||||
| Repayment on term debt | |||||
| Proceeds from exercise of stock options, including tax benefit | |||||
| Net cash provided by financing activities | |||||
| Net cash provided by financing activities | |||||
| Cash and Cash Equivalents, Period Increase (Decrease), Total | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental non cash disclosure | |||||
| Loan balances transferred to foreclosed real estate | |||||
| Loan balances transferred to loans held for sale | |||||
Loading...
